A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...
Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...
Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: The Biopharmaceutical Contract ...
Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...
Armed with $115 million and a clinical-stage asset, another player is emerging in the increasingly crowded T cell engager ...
Role of Real-World Evidence (RWE) in Driving Pharmaceutical R&D Outsourcing Market Growth ...
The Prevnar 20 approval comes a few weeks ahead of an FDA decision on Merck's V114, which was granted a priority review by the regulator in January for the prevention of IPD in adults.
Several major wildfires are burning in Los Angeles County. At least 10 people have died, but officials warn the actual toll will remain unclear until it’s safe for investigators to access ...
In response to the devastating fires across Los Angeles, Princess Cruises provides aid and flexible cancellation options to impacted passengers.